Hyperacute rejection of renal homografts: with particular reference to coaglation changes, humoral antibodies, and formed blood elements.

The evaluation of human histocompatibility matching in renal transplant recipients has not been possible with anything like the precision of a controlled laboratory experiment. One reason has been that varying degrees of patient presensitization may occur to antigens present in the eventual organ donor. The consequence of this unfavorable condition may be accelerated or even hyperacute rejection in spite of an apparently good histocompatibility match. In recent years, increasing numbers of human renal homografts have been lost by hyperacute rejection. Although much has been learned about the complication, several aspects of its pathogenesis have remained unclear either because of seemingly contradictory reports in the clinical literature or because of insufficient experimental information about the interlocking roles of humoral antibodies, coagulation, and formed blood elements in the process of destruction. Consequently, this paper will attempt to clarify the existing state of knowledge about hyperacute rejection by presenting a historical review of the subject and by describing several laboratory experiments designed to provide detailed data about the very earliest events of this form of graft destruction.

[1]  T. Starzl,et al.  Mechanism and modification of rejection of heterografts between divergent species. , 1970, Transplantation proceedings.

[2]  T. Starzl,et al.  Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. , 1970, The New England journal of medicine.

[3]  C. Wilson,et al.  Antigen quantitation in experimental immune complex glomerulonephritis. I. Acute serum sickness. , 1970, Journal of immunology.

[4]  T. Starzl,et al.  Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. , 1970, Surgery.

[5]  J. Menzoian,et al.  HEPARIN AND ASPIRIN IN THE TREATMENT OF HYPERACUTE REJECTION OF RENAL ALLOGRAFTS IN PRESENSITIZED DOGS , 1970, Transplantation.

[6]  M. Bier,et al.  Selective plasmapheresis in dogs for delay of heterograft response. , 1970, Transactions - American Society for Artificial Internal Organs.

[7]  J. Merrill,et al.  Failure to detect evidence for intravascular coagulation during acute renal allograft rejection. , 1970, Transplantation.

[8]  J. Klassen,et al.  THE ROLE OF HUMORAL ANTIBODIES IN THE REJECTION OF RENAL HOMOGRAFTS BY RABBITS , 1969, Transplantation.

[9]  R. Colman,et al.  Coagulation Studies in the Hyperacute and Other Forms of Renal-Allograft Rejection , 1969 .

[10]  A. Sheil,et al.  ABO blood group incompatibility in renal transplantation. , 1969, Transplantation.

[11]  I. Cohen,et al.  Hyperacute rejection in human-kidney allografts-shwartzman or arthus reaction? , 1969, The New England journal of medicine.

[12]  Hume Dm,et al.  Hyperacute rejection of dog renal autografts. , 1969 .

[13]  J. Dausset,et al.  Erythrocytes in human transplantation: effects of pretreatment with ABO group-specific antigens. , 1968, The Journal of clinical investigation.

[14]  P. Morris,et al.  "Hyperacute" renal-homograft rejection in man. , 1968, The New England journal of medicine.

[15]  R. Varco,et al.  Humoral factors in canine renal allograft rejection. , 1968, Lancet.

[16]  R. Lerner,et al.  Shwartzman reaction after human renal homotransplantation. , 1968, The New England journal of medicine.

[17]  D. Hume,et al.  Studies in hyperacute and chronic renal homograft rejection in man , 1968 .

[18]  R. Varco,et al.  HUMORAL FACTORS IN CANINE RENAL ALLOGRAFT REJECTION , 1968 .

[19]  R. Lerner,et al.  Shwartzman reaction after human renal transplantation , 1968 .

[20]  O. Fjeldborg,et al.  Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells , 1967 .

[21]  C. Abildgaard,et al.  A semiautomatic one-stage factor 8 assay with a commercially prepared standard. , 1967, The Journal of laboratory and clinical medicine.

[22]  K. Kano,et al.  Humoral Antibodies in Renal Homograft , 1966 .

[23]  Y. Takeda Studies of the metabolism and distribution of fibrinogen in healthy men with autologous 125-I-labeled fibrinogen. , 1966, The Journal of clinical investigation.

[24]  T. Starzl,et al.  Sero-typing of human lymphocyte antigens: Preliminary trials on long-term kidney homograft survivors , 1965 .

[25]  D. Mckay Disseminated intravascular coagulation : an intermediary mechanism of disease , 1965 .

[26]  R. Varco,et al.  COMPLEMENT FIXATION DURING HOMOGRAFT REJECTION. , 1965, Surgical forum.

[27]  R. Aster,et al.  PLATELET SEQUESTRATION IN MAN. I. METHODS. , 1964, The Journal of clinical investigation.

[28]  T. Starzl,et al.  RENAL HOMOGRAFTS IN PATIENTS WITH MAJOR DONOR-RECIPIENT BLOOD GROUP INCOMPATIBILITIES. , 1964, Surgical forum.

[29]  J. J. Rood,et al.  LEUKOCYTE GROUPING. A METHOD AND ITS APPLICATION , 1963 .

[30]  E. Henderson,et al.  The thrombotic activity of activation product. , 1962, The Journal of clinical investigation.

[31]  R. R. Proctor,et al.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. , 1961, American journal of clinical pathology.

[32]  M. Derechin The assay of human plasminogen with casein as substrate. , 1961, The Biochemical journal.

[33]  A. E. Szulman THE HISTOLOGICAL DISTRIBUTION OF BLOOD GROUP SUBSTANCES A AND B IN MAN , 1960, The Journal of experimental medicine.

[34]  C. Högman Blood Group Antigens A and B Determined by Means of Mixed Agglutination on Cultured Cells of Human Fetal Kidney, Liver, Spleen, Lung, Heart and Skin * , 1959 .

[35]  M. Buckell THE EFFECT OF CITRATE ON EUGLOBULIN METHODS OF ESTIMATING FIBRINOLYTIC ACTIVITY , 1958, Journal of clinical pathology.

[36]  O. Ratnoff,et al.  A new method for the determination of fibrinogen in small samples of plasma. , 1951, The Journal of laboratory and clinical medicine.

[37]  P. Owren,et al.  The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. , 1951, Scandinavian journal of clinical and laboratory investigation.

[38]  E. Cronkite,et al.  Morphology and enumeration of human blood platelets. , 1950, Journal of applied physiology.